Blood Protein LRG as a Marker for Healing in Ulcerative Colitis
Studies whether a blood level of LRG predicts microscopic healing in ulcerative colitis patients.
Plain-language title generated from the registry record
Registry title: Association Between LRG and Histologic Remission in Ulcerative Colitis
Key facts
- Where
- Komagane, JapanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Source: NCT06372613, who can take part
Where in Japan
- Showa Inan General HospitalKomagane, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Showa Inan General Hospital
- Trial code
- NCT06372613
- Record updated
- 13 August 2026
- Original description
We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed annually, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.Read full original descriptionShow less
What is the Level of Serum Leucine-rich α 2-glycoprotein (LRG) Which Predicts Histologic Remission in Patients With Ulcerative Colitis?
We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed annually, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.
Inclusion: definitive UC patients based on the standard criteria.
Exclusion: None.